Anna Aronova

NewYork–Presbyterian Hospital

Papers

2

Total Citations

85

H-Index

2

About

Anna Aronova is a distinguished researcher whose work bridges endocrinology and surgical education, with a focus on hypertension management and robotic surgery training. Her key contributions center on primary aldosteronism (PA), the most common reversible cause of hypertension, affecting 5–18% of adults. In her highly cited 2014 paper (51 citations), Aronova advanced understanding of PA management, highlighting its role in reducing cardiovascular and renal morbidity—a critical insight for clinicians treating drug-resistant hypertension. She also explores surgical innovation, as seen in her 2015 study (34 citations) on robotic surgery training for general surgery residents, where she assessed skill acquisition and curriculum effectiveness. This work underscores her commitment to improving both patient outcomes and surgical education. With over 85 combined citations from these landmark studies, Aronova’s research has practical implications for endocrinologists, surgeons, and educators, positioning her as a key voice in translating complex clinical challenges into actionable training and treatment strategies.

Research Focus

Key Achievements

2
H-Index
2
Papers
85
Total Citations
43
Avg Citations/Paper
🏆 Most Cited Paper
Management of hypertension in primary aldosteronism
51 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: NewYork–Presbyterian Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago